Evaluation of Muscle Involvement in Systemic Sclerosis

Launched by CENTRAL HOSPITAL, NANCY, FRANCE · Sep 21, 2023

Keywords

ClinConnect Summary

This clinical trial is studying how muscle involvement affects patients with systemic sclerosis (SSc), a condition that can cause hardening and tightening of the skin and connective tissues. Researchers are particularly interested in understanding how common muscle damage is among SSc patients and how it relates to other issues like heart problems and certain antibodies. By examining symptoms and testing results, they hope to identify different groups of patients based on their muscle involvement.

To participate in this trial, patients must have been diagnosed with systemic sclerosis according to specific classification criteria. The trial is currently recruiting participants of all genders and ages 65 to 74. Those who join will undergo various tests to assess muscle function and involvement, and they can expect to contribute valuable information that may help improve the understanding and treatment of SSc in the future. Overall, this study aims to shed light on the muscular symptoms connected to systemic sclerosis, which have not been well documented so far.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients with systemic sclerosis according to 2013 ACR/EULAR classification criteria